Abstract
Inhibition of mammalian target of rapamycin complex I (mTORC1) by rapamycin improves cardiac function in both aging and heart failure. While the protective mechanisms are not fully understood in mammals, they are presumably mediated through metabolic regulation and suppression of protein translation by reduced phosphorylation of 4EBP1, a target of mTORC1. Using transverse aortic constriction (TAC) and Gαq overexpression-induced heart failure models, we examined the effect of cardiac-specific heterozygous deletion (het) of Raptor, a component of mTORC1, and cardiac-specific transgenic overexpression of wild type or phosphorylation site mutant 4EBP1. In wild-type mice with TAC-induced heart failure, quantitative shotgun proteomics revealed decreased abundance of proteins of mitochondrial metabolism and increased abundance of proteins in oxidative stress response, ubiquitin, and other pathways. The Raptor het ameliorated both TAC- and Gαq overexpression-induced heart failure and the associated proteomic remodeling, especially those pathways involved in mitochondrial function, citric acid cycle, and ubiquitination. In contrast, transgenic overexpression of either wild type or mutant 4EBP1 aggravated TAC and Gαq, consistent with reduced adaptive hypertrophy by suppression of protein translation, in parallel with adverse remodeling of left ventricular proteomes. Partial mTORC1 inhibition by Raptor heterozygous deletion ameliorates heart failure and is associated with better preservation of the mitochondrial proteome; however, this effect does not appear to be mediated through suppression of protein translation by increased 4EBP1. Increased activity of 4EBP1 reduced adaptive hypertrophy and aggravated heart failure, suggesting that protein translation is essential for adaptive hypertrophy in pressure overload.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
D’Angelo DD, Sakata Y, Lorenz JN, Boivin GP, Walsh RA, Liggett SB, Dorn GW 2nd (1997) Transgenic Galphaq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci U S A 94:8121–8126
Dai DF, Santana LF, Vermulst M, Tomazela DM, Emond MJ, MacCoss MJ, Gollahon K, Martin GM, Loeb LA, Ladiges WC, Rabinovitch PS (2009) Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging. Circulation 119:2789–2797. https://doi.org/10.1161/CIRCULATIONAHA.108.822403
Dai DF, Chen T, Szeto H, Nieves-Cintron M, Kutyavin V, Santana LF, Rabinovitch PS (2011a) Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy. J Am Coll Cardiol 58:73–82. https://doi.org/10.1016/j.jacc.2010.12.044
Dai DF et al (2011b) Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure. Circ Res 108:837–846. https://doi.org/10.1161/CIRCRESAHA.110.232306
Dai DF et al (2012) Mitochondrial proteome remodelling in pressure overload-induced heart failure: the role of mitochondrial oxidative stress. Cardiovasc Res 93:79–88. https://doi.org/10.1093/cvr/cvr274
Dai DF et al (2013) Global proteomics and pathway analysis of pressure-overload-induced heart failure and its attenuation by mitochondrial-targeted peptides. Circ Heart Fail 6:1067–1076. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000406
Dai DF et al (2014) Altered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart. Aging Cell 13:529–539. https://doi.org/10.1111/acel.12203
Fang Y et al (2013) Duration of rapamycin treatment has differential effects on metabolism in mice. Cell Metab 17:456–462. https://doi.org/10.1016/j.cmet.2013.02.008
Gangloff YG et al (2004) Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development. Mol Cell Biol 24:9508–9516. https://doi.org/10.1128/MCB.24.21.9508-9516.2004
Gao XM et al (2006) Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis. J Hypertens 24:1663–1670. https://doi.org/10.1097/01.hjh.0000239304.01496.83
Gentleman RC et al (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80. https://doi.org/10.1186/gb-2004-5-10-r80
Guertin DA, Sabatini DM (2007) Defining the role of mTOR in cancer. Cancer Cell 12:9–22. https://doi.org/10.1016/j.ccr.2007.05.008
Harrison DE et al (2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460:392–395. https://doi.org/10.1038/nature08221
Kall L, Canterbury JD, Weston J, Noble WS, MacCoss MJ (2007) Semi-supervised learning for peptide identification from shotgun proteomics datasets. Nat Methods 4:923–925. https://doi.org/10.1038/nmeth1113
Kenyon CJ (2010) The genetics of ageing. Nature 464:504–512. https://doi.org/10.1038/nature08980
Kim Y et al (2008) The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice. J Clin Invest 118:124–132. https://doi.org/10.1172/JCI33255
Kim M, Shen M, Ngoy S, Karamanlidis G, Liao R, Tian R (2012) AMPK isoform expression in the normal and failing hearts. J Mol Cell Cardiol 52:1066–1073. https://doi.org/10.1016/j.yjmcc.2012.01.016
Lamming DW et al (2012) Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 335:1638–1643. https://doi.org/10.1126/science.1215135
Lamming DW, Ye L, Sabatini DM, Baur JA (2013) Rapalogs and mTOR inhibitors as anti-aging therapeutics. J Clin Invest 123:980–989. https://doi.org/10.1172/JCI64099
Li S, Sonenberg N, Gingras AC, Peterson M, Avdulov S, Polunovsky VA, Bitterman PB (2002) Translational control of cell fate: availability of phosphorylation sites on translational repressor 4E-BP1 governs its proapoptotic potency. Mol Cell Biol 22:2853–2861
McMullen JR, Sherwood MC, Tarnavski O, Zhang L, Dorfman AL, Shioi T, Izumo S (2004a) Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload. Circulation 109:3050–3055. https://doi.org/10.1161/01.CIR.0000130641.08705.45
McMullen JR et al (2004b) Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy. Mol Cell Biol 24:6231–6240. https://doi.org/10.1128/MCB.24.14.6231-6240.2004
Miller RA et al (2011) Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci 66:191–201. https://doi.org/10.1093/gerona/glq178
Murakami M et al (2004) mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol Cell Biol 24:6710–6718. https://doi.org/10.1128/MCB.24.15.6710-6718.2004
Niemann B, Chen Y, Issa H, Silber RE, Rohrbach S (2010) Caloric restriction delays cardiac ageing in rats: role of mitochondria. Cardiovasc Res 88:267–276. https://doi.org/10.1093/cvr/cvq273
Sadoshima J, Qiu Z, Morgan JP, Izumo S (1995) Angiotensin II and other hypertrophic stimuli mediated by G protein-coupled receptors activate tyrosine kinase, mitogen-activated protein kinase, and 90-kD S6 kinase in cardiac myocytes. The critical role of Ca(2+)-dependent signaling. Circ Res 76:1–15
Schreiber KH et al (2019) A novel rapamycin analog is highly selective for mTORC1 in vivo. Nat Commun 10:3194. https://doi.org/10.1038/s41467-019-11174-0
Selman C et al (2009) Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science 326:140–144. https://doi.org/10.1126/science.1177221
Sengupta S, Peterson TR, Sabatini DM (2010) Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell 40:310–322. https://doi.org/10.1016/j.molcel.2010.09.026
Shende P et al (2011) Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice. Circulation 123:1073–1082. https://doi.org/10.1161/CIRCULATIONAHA.110.977066
Shinmura K, Tamaki K, Sano M, Murata M, Yamakawa H, Ishida H, Fukuda K (2011) Impact of long-term caloric restriction on cardiac senescence: caloric restriction ameliorates cardiac diastolic dysfunction associated with aging. J Mol Cell Cardiol 50:117–127. https://doi.org/10.1016/j.yjmcc.2010.10.018
Shioi T, McMullen JR, Tarnavski O, Converso K, Sherwood MC, Manning WJ, Izumo S (2003) Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation 107:1664–1670. https://doi.org/10.1161/01.CIR.0000057979.36322.88
Steffen KK et al (2008) Yeast life span extension by depletion of 60s ribosomal subunits is mediated by Gcn4. Cell 133:292–302. https://doi.org/10.1016/j.cell.2008.02.037
Taffet GE, Pham TT, Hartley CJ (1997) The age-associated alterations in late diastolic function in mice are improved by caloric restriction. J Gerontol A Biol Sci Med Sci 52:B285–B290
Tarnavski O, McMullen JR, Schinke M, Nie Q, Kong S, Izumo S (2004) Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. Physiol Genomics 16:349–360. https://doi.org/10.1152/physiolgenomics.00041.2003
Tian R, Musi N, D’Agostino J, Hirshman MF, Goodyear LJ (2001) Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy. Circulation 104:1664–1669
Tsai S et al (2015) Muscle-specific 4E-BP1 signaling activation improves metabolic parameters during aging and obesity. J Clin Invest 125:2952–2964. https://doi.org/10.1172/JCI77361
Wessells R et al (2009) d4eBP acts downstream of both dTOR and dFoxo to modulate cardiac functional aging in Drosophila. Aging Cell 8:542–552. https://doi.org/10.1111/j.1474-9726.2009.00504.x
Zhang D et al (2010) MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. J Clin Invest 120:2805–2816. https://doi.org/10.1172/JCI43008
Zid BM et al (2009) 4E-BP extends lifespan upon dietary restriction by enhancing mitochondrial activity in Drosophila. Cell 139:149–160. https://doi.org/10.1016/j.cell.2009.07.034
Funding
This work was supported by a funding from the National Institute of Health: R01 AG038550, P30AG013280, R01 HL101186, an Ellison Medical Foundation award AG-SS-2535-10 to P.S.R., R01 AG033082 to A.R.L. and K08 HL145138 to DF.D.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
All animal experiments were approved by the University of Washington Institutional Animal Care and Use Committee.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(PDF 980 kb)
About this article
Cite this article
Dai, DF., Liu, Y., Basisty, N. et al. Differential effects of various genetic mouse models of the mechanistic target of rapamycin complex I inhibition on heart failure. GeroScience 41, 847–860 (2019). https://doi.org/10.1007/s11357-019-00119-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11357-019-00119-6